The D647N mutation of FGFR1 induces ligand-independent receptor activation

Mattia Domenichini(University of Brescia), Stefania Mitola(University of Brescia)

Biochimica et Biophysica Acta (BBA) - General Subjects

September 29, 2023

10.1016/j.bbagen.2023.130470

Cited by 3

Related Papers

Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine

|The Journal of Immunology|2006|225

Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2

|Blood|2010|205

Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist

|Oncotarget|2016|50

A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis

|Cancer Letters|2020|19

Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts

|Neoplasia|2025|3